NME4 and breast neoplasm: We first analyzed NME4 transcript levels by RTqPCR of a panel of human breast tumor cell lines according to their normal-like, hormone receptor (HR)-positive, and triple-negative (HR- and HER2-negative) status, where the HR-positive subtype has a more favorable prognosis than the triple-negative subtype (Additional file 14: Fig. S8).